NCT05650892

Brief Summary

Thoracic aortic aneurysms (TAA) result from progressive dilatation of the thoracic aorta and confer a risk for aortic dissection or rupture, which is associated with significant morbidity and mortality. In the Netherlands there are an estimated 200.000 adults with TAA, and annually 600 deaths after aortic dissection or rupture. There are clear differences in the incidence of TAA between men and women, with a higher incidence in men. Little is known on possible differences in outcome between male and female patients with Thoracic Aortic Aneurysm (TAA). Aortic disease is thought to affect men more frequently than women, and aortic growth is different between men and women. Current data suggest that women are at an increased risk of both dying from aortic dissection and having aorta-related complications compared to men (1). The mechanisms for these male-female difference in TAA outcome remain, however, unclear. The timing of preventive surgery is now not different for men and women, but gender-based cut-off values for maximal aortic diameter based on differences in vessel wall composition might be needed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

June 7, 2022

Completed
6 months until next milestone

First Posted

Study publicly available on registry

December 14, 2022

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 16, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

February 22, 2023

Status Verified

February 1, 2023

Enrollment Period

1.9 years

First QC Date

June 7, 2022

Last Update Submit

February 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Male-female differences in immunohistochemical and mass spectrometry-based estrogen and testosterone receptor expression levels (and density) in the proximal aortic wall

    To investigate male-female differences in estrogen receptor (ESR-alpha and ESRbeta) and testosterone receptor (AR) tissue expression in the wall of the aortic root and ascending aorta by immunohistochemical techniques and mass spectometry. Comparisons will be made using a students t-test.

    1 year

Secondary Outcomes (1)

  • Male-female differences in immunohistochemical or mass spectrometry-based sex hormone receptor expression levels (and density) in the proximal aortic wall.

    1 year

Study Arms (1)

Sample collection aortic tissue

Sample collection thoracic aorta tissue

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults (≥18 years old) who will undergo or already underwent elective surgery for thoracic aortic aneurysm at Erasmus MC, Rotterdam and LUMC, Leiden.

You may qualify if:

  • Adult patients (≥ 18 years old) who have a thoracic aortic aneurysm and are scheduled for elective thoracic aortic surgery in the Erasmus MC or the LUMC.

You may not qualify if:

  • Patients with a known connective tissue disease (e.g. Marfan Syndrome and Ehlers-Danlos syndromes).
  • Connective tissue disease,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erasmus MC

Rotterdam, 3000 CA, Netherlands

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Thoracic aorta (residual tissue).

MeSH Terms

Conditions

Aortic Aneurysm, Thoracic

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Study Officials

  • Hanneke Takkenberg, Prof. dr.

    Erasmus Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. dr.

Study Record Dates

First Submitted

June 7, 2022

First Posted

December 14, 2022

Study Start

February 1, 2021

Primary Completion

December 16, 2022

Study Completion

December 31, 2023

Last Updated

February 22, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will share

All our anonymised individual patient data (IPD) will be available to other researchers, upon reasonable request and after publication of the manuscript. This includes IPD derived from all analyses that were performed for and used in this study.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will become available upon request after a period of twelve months from the date of publication. The length of availability of IPD will depend on and therefore be based on the request of the researchers.
Access Criteria
IPD will be shared with scientific researchers and is dependent on the research questions. The analysis and interpretation by the researcher will be checked by the project leader before any submission of the manuscript.

Locations